Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Collier

Showing results (601-610 of 760) with videos related to

Pageof 76
Sort By:
Cancer Chemotherapy and Pharmacology|May 10, 2000
Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeksJ D Roberts, S Shibata, D V Spicer, et al.
Psychological Medicine|February 28, 2013
White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatmentQ Wang, C Cheung, W Deng, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adultsP Barditch-Crovo, S G Deeks, A Collier, et al.
Neuroimage|March 23, 2011
Differential effects of DAAO on regional activation and functional connectivity in schizophrenia, bipolar disorder and controlsSergio Alessandro Papagni, Andrea Mechelli, Diana P Prata, et al.
Nature Communications|November 20, 2018
Author Correction: Expression-based drug screening of neural progenitor cells from individuals with schizophreniaBenjamin Readhead, Brigham J Hartley, Brian J Eastwood, et al.
Plos One|January 13, 2017
Probing the Association between Early Evolutionary Markers and SchizophreniaSaurabh Srinivasan, Francesco Bettella, Sahar Hassani, et al.
Genes, Brain, and Behavior|November 25, 2010
No association of Disrupted-in-Schizophrenia-1 variation with prefrontal function in patients with schizophrenia and bipolar disorderD P Prata, A Mechelli, M Picchioni, et al.
Molecular Psychiatry|January 17, 2019
A genome-wide association study in individuals of African ancestry reveals the importance of the Duffy-null genotype in the assessment of clozapine-related neutropeniaSophie E Legge, Antonio F Pardiñas, Marinka Helthuis, et al.
International Journal of Pharmaceutics|December 3, 2014
Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infectionKy V Hoang, Hassan M Borteh, Murugesan V S Rajaram, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 11, 2007
Family-based association analysis of functional VNTR polymorphisms in the dopamine transporter gene in migraine with and without auraA Karwautz, S Campos de Sousa, A Konrad, et al.
Pageof 76

Showing results (601-610 of 760) with videos related to

Sort By:
Pageof 76
Cancer Chemotherapy and Pharmacology|May 10, 2000
Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeksJ D Roberts, S Shibata, D V Spicer, et al.
Psychological Medicine|February 28, 2013
White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatmentQ Wang, C Cheung, W Deng, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adultsP Barditch-Crovo, S G Deeks, A Collier, et al.
Neuroimage|March 23, 2011
Differential effects of DAAO on regional activation and functional connectivity in schizophrenia, bipolar disorder and controlsSergio Alessandro Papagni, Andrea Mechelli, Diana P Prata, et al.
Nature Communications|November 20, 2018
Author Correction: Expression-based drug screening of neural progenitor cells from individuals with schizophreniaBenjamin Readhead, Brigham J Hartley, Brian J Eastwood, et al.
Plos One|January 13, 2017
Probing the Association between Early Evolutionary Markers and SchizophreniaSaurabh Srinivasan, Francesco Bettella, Sahar Hassani, et al.
Genes, Brain, and Behavior|November 25, 2010
No association of Disrupted-in-Schizophrenia-1 variation with prefrontal function in patients with schizophrenia and bipolar disorderD P Prata, A Mechelli, M Picchioni, et al.
Molecular Psychiatry|January 17, 2019
A genome-wide association study in individuals of African ancestry reveals the importance of the Duffy-null genotype in the assessment of clozapine-related neutropeniaSophie E Legge, Antonio F Pardiñas, Marinka Helthuis, et al.
International Journal of Pharmaceutics|December 3, 2014
Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infectionKy V Hoang, Hassan M Borteh, Murugesan V S Rajaram, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 11, 2007
Family-based association analysis of functional VNTR polymorphisms in the dopamine transporter gene in migraine with and without auraA Karwautz, S Campos de Sousa, A Konrad, et al.
Pageof 76